Mazzella G, Cipolla A, Villanova N, Polimeni C, Sipahi A, Parini P, Fusaroli P, Festi D, Roda E
Cattedra di Gastroenterologia, Università di Bologna, Italy.
Ital J Gastroenterol. 1995 Oct-Nov;27(8):441-5.
The aim of this work was to evaluate and compare the effects of a low calorie diet (1026 kcal), simvastatin and ursodeoxycholic acid administration on biliary lipid secretion and cholic acid kinetics in dieting obese subjects. We studied 6 obese subjects before and after four weeks of a hypocaloric diet alone, after four weeks of diet plus ursodeoxycholic acid (900 mg/day) and after four weeks of diet plus simvastatin (40 mg/day), according to a Latin square design. The cholesterol saturation index was increased after diet alone, significantly reduced with diet plus ursodeoxycholic acid (p < 0.01), and unchanged during simvastatin administration. While the cholesterol output was reduced by all three regimens, diet plus ursodeoxycholic acid caused a significantly greater decrease than diet alone (p < 0.01). Cholic acid synthesis and bile acid secretion were decreased by diet and diet plus simvastatin (p < 0.05), but neither was affected by ursodeoxycholic acid. For cholic acid, all three treatments, but especially diet alone and diet plus simvastatin (p < 0.05), reduced the pool size; all three regimens also increased the turnover rate, but this was significant only for ursodeoxycholic acid (p < 0.01). Our study shows that, in obese patients, a hypocaloric diet reduces cholesterol-holding biliary lipid output and consequently increases the cholesterol saturation index. The addition of simvastatin to a hypocaloric dietary regimen reduces cholesterol secretion, but without variation in bile acid and phospholipid output thus the cholesterol saturation index remains unchanged. When ursodeoxycholic acid is added to the dietary regimen, it reduces cholesterol secretion, while maintaining bile acid output and, thus, lowers the cholesterol saturation index. Unlike simvastatin, ursodeoxycholic acid prevents the drop in cholic acid synthesis induced by a low calorie diet.
这项研究的目的是评估和比较低热量饮食(1026千卡)、辛伐他汀和熊去氧胆酸给药对节食肥胖受试者胆汁脂质分泌和胆酸动力学的影响。我们根据拉丁方设计,对6名肥胖受试者在单独进行四周低热量饮食前后、四周饮食加熊去氧胆酸(900毫克/天)后以及四周饮食加辛伐他汀(40毫克/天)后进行了研究。单独饮食后胆固醇饱和指数升高,饮食加熊去氧胆酸后显著降低(p<0.01),而在服用辛伐他汀期间无变化。虽然三种方案均使胆固醇排出量减少,但饮食加熊去氧胆酸导致的减少幅度显著大于单独饮食(p<0.01)。饮食以及饮食加辛伐他汀使胆酸合成和胆汁酸分泌减少(p<0.05),但熊去氧胆酸对二者均无影响。对于胆酸,所有三种治疗方法,尤其是单独饮食和饮食加辛伐他汀(p<0.05),均使胆酸池大小减小;所有三种方案还提高了周转率,但仅熊去氧胆酸的这种作用具有显著性(p<0.01)。我们的研究表明,在肥胖患者中,低热量饮食可降低含胆固醇的胆汁脂质排出量,从而增加胆固醇饱和指数。在低热量饮食方案中添加辛伐他汀可降低胆固醇分泌,但胆汁酸和磷脂排出量无变化,因此胆固醇饱和指数保持不变。当在饮食方案中添加熊去氧胆酸时,它可降低胆固醇分泌,同时维持胆汁酸排出量,从而降低胆固醇饱和指数。与辛伐他汀不同,熊去氧胆酸可防止低热量饮食引起的胆酸合成下降。